SB 1602: Cancer Clinical Trials
GENERAL BILL by Simmons
Cancer Clinical Trials; Requiring cancer clinical trial programs to inform prospective patient subjects of the specified reimbursements for ancillary costs and travel expenses which may be available to them and their caregivers if they participate in a cancer clinical trial; specifying that reimbursement offers may not be coercive or exert an undue influence and are not considered inducements for participation; requiring certain entities that offer reimbursement programs to secure the informed consent of patient subjects, etc.
Effective Date: 7/1/2019
Last Action: 5/3/2019 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Last Action: 5/3/2019 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Senate Committee References:
- Health Policy (HP)
- Banking and Insurance (BI)
- Rules (RC)
Bill History
| Date | Chamber | Action |
|---|---|---|
| 3/1/2019 | Senate |
• Filed |
| 3/8/2019 | Senate |
• Referred to Health Policy; Banking and Insurance; Rules -SJ 208 |
| 3/13/2019 | Senate |
• Introduced -SJ 208 |
| 5/3/2019 | Senate |
• Indefinitely postponed and withdrawn from consideration • Died in Health Policy |